Abstract:Chronic obstructive pulmonary disease (COPD) is a respiratory disease that has a major impact worldwide. The currently-available drugs mainly focus on relieving the symptoms of COPD patients. Novel regenerative therapeutic approaches have been investigated with the aim of repairing or replacing the injured functional structures of the respiratory system. We summarized the progress made by regenerative therapies for COPD by analyzing results from both pre-clinical studies and completed clinical trials. These approaches include the application of exogenous stem cells or small molecules to stimulate the regeneration by endogenous lung stem/progenitor cells. Exogenous mesenchymal stem cells (MSCs) have been reported to repair the structure and improve the function of the injured respiratory system in COPD models. However, the studies that used MSCs in patients with moderate-to-severe COPD patients did not lead to clear respiratory functional improvements. Exogenous human lung stem cells applied to cryo-injured (CI) lungs of mice have been shown to organize into human-like pulmonary structures, indicating a new property of stem cells that is potentially capable of curing COPD patients. Small molecules like retinoic acid has been shown to lead to regeneration and repair of the damaged lung structures in COPD mouse models probably by activation of endogenous lung stem/progenitor cells. However, retinoic acid or agonists of retinoic acid receptor administered to moderate or severe COPD patients did not improve the density and function of the damaged lung. These novel regenerative approaches have failed in preliminary clinical trials, possibly due to the advanced severity of the disease. Further work should be done to develop the current regenerative approaches for curing patients at different stages of COPD. We suggest that some modifications of the approach in the clinical studies may lead to more successful outcomes of regenerative therapy for COPD.

Lung tissue bioengineering for chronic obstructive pulmonary disease: overcoming the need for lung transplantation from human donors

Heterotopic Lung Transplant: a Feasible Approach to Compensate for Organ Shortages

Bioengineering lungs: An overview of current methods, requirements, and challenges for constructing scaffolds

Emerging Paradigms in Bioengineering the Lungs

Lung Progenitor and Stem Cell Transplantation as a Potential Regenerative Therapy for Lung Diseases

Lung regeneration and lung bioengineering

Lung Transplant for Chronic Obstructive Pulmonary Disease

Creating superior lungs for transplantation with next-generation gene therapy during ex vivo lung perfusion

How do we expand the lung donor pool?

Advancement of Lung Tissue Engineering: an Overview

Bioengineering lungs — current status and future prospects

Transplantation of bioengineered lung using decellularized mouse lungs and primary human endothelial cells.

Future directions for xenotransplantation in lungs

Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality?

Time to Rethink Bronchiolitis Obliterans Syndrome Following Lung or Hematopoietic Cell Transplantation in Pediatric Patients

Past and Future of Alveolar Organoids for Lung Regenerative Medicine

Progress towards permanent respiratory support

Orthotopic transplantation of the bioengineered lung using a mouse-scale perfusion-based bioreactor and human primary endothelial cells

History of Lung Transplantation

Lung transplantation: from the procedure to managing patients with lung transplantation

Stem cell therapies for chronic obstructive pulmonary disease: current status of pre-clinical studies and clinical trials